GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (OTCPK:ULIHF) » Definitions » 3-Year EPS without NRI Growth Rate

United Laboratories International Holdings (United Laboratories International Holdings) 3-Year EPS without NRI Growth Rate : 35.20% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is United Laboratories International Holdings 3-Year EPS without NRI Growth Rate?

United Laboratories International Holdings's EPS without NRI for the six months ended in Dec. 2023 was $0.11.

During the past 12 months, United Laboratories International Holdings's average EPS without NRI Growth Rate was 65.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 35.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 40.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of United Laboratories International Holdings was 86.20% per year. The lowest was -41.50% per year. And the median was 24.20% per year.


Competitive Comparison of United Laboratories International Holdings's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's 3-Year EPS without NRI Growth Rate falls into.



United Laboratories International Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


United Laboratories International Holdings  (OTCPK:ULIHF) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


United Laboratories International Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (United Laboratories International Holdings) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (United Laboratories International Holdings) Headlines

No Headlines